Amyloid beta induces cPLA2 activation by an NADPH oxidase-dependent mechanism in neurons
No Thumbnail Available
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Thesis
Subject
Abstract
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Alzheimer's disease (AD) is a neurodegenerative disorder affecting more than 20 million people worldwide. An increase in production of amyloid beta peptides (A[Beta]) and their aggregation to the oligomeric form is thought to contribute to neurotoxicity in the AD brain. cPLA2 is an enzyme responsible for hydrolysis of fatty acids in the sn-2 position of membrane phospholipids. Substantial attention has been paid to arachidonic acid (AA) because this lipid mediator is not only used for prostanoid synthesis but is also regarded as a retrograde transmitter. cPLA2 has been implicated in the pathogenesis of a number of neurodegenerative diseases including AD. Recent studies provided evidence for the production of reactive oxygen species (ROS) in association with glutamate excitotoxicity and involvement of NMDA receptors in A[Beta]-induced neurotoxicity. This study is focused on elucidating the role of NADPH oxidase, a superoxide producing enzyme, on the signaling pathway leading to cPLA2 activation and AA release in cortical neurons. Results show that A[Beta] and NMDA can produce ROS in neurons via NADPH oxidase and that this pool of ROS is important for ERK1/2 phosphorylation, cPLA2 phosphorylation and subsequent AA release. The study presented here identifies for the first time the importance of the ROS producing enzyme NADPH oxidase in the signaling pathway leading to A[Beta]-induced and NMDA receptor-mediated cPLA2 activation in neurons. This novel mechanism may contribute to a better understanding of the oxidative mechanism underlying the pathogenesis of AD.
Table of Contents
DOI
PubMed ID
Degree
Ph. D.
Thesis Department
Rights
Access is limited to the campus of the University of Missouri--Columbia.